Vimarsana
Biggest News Aggregation in the World

Orbimed Royalty News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Orbimed Royalty. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Orbimed Royalty Today - Breaking & Trending Today

MDxHealth : Extraordinary GENERAL MEETING Form 6 K - Vimarsana News

MDxHealth : Extraordinary GENERAL MEETING Form 6 K

Extraordinary GENERAL MEETING to be held on Thursday, 20 June 2024, at 3:00 p.m. As the quorum for the deliberation and voting on the...

Insmed Announces Proposed $500 Million Public Offering of Common Stock - Vimarsana News

Insmed Announces Proposed $500 Million Public Offering of Common Stock

BRIDGEWATER, N.J., May 28, 2024 /PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today

Insmed Announces Proposed $500 Million Public Offering of Common Stock - Vimarsana News

Insmed Announces Proposed $500 Million Public Offering of Common Stock

BRIDGEWATER, N.J., May 28, 2024 /PRNewswire/ -- Insmed Incorporated , a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today...

Insmed to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International Conference - Vimarsana News

Insmed to Present New Data from Across its Respiratory Portfolio at the American Thoracic Society 2024 International Conference

/PRNewswire/ -- Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare...

Insmed Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference - Vimarsana News

Insmed Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference

—ARIKAYCE® (amikacin liposome inhalation suspension) Delivers Full-Year 2023 Revenues Exceeding the Upper End of Guidance Range with Unaudited Global Net...